Trevi Therapeutics to Present at 2021 BIO Digital Conference

Trevi Therapeutics Announces First Quarter 2021 Financial Results and Business Update

Phase 2b/3 PRISM (Chronic Pruritus in PN) Trial Over 70% Enrolled

Trevi Therapeutics to Report Q1 2021 Financial Results on May 13

Conference Call and Webcast to be Held at 4:30 p.m. ET